Santiago Vieira

Dr. Santiago Vieira

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
PDF file
SVSantiago Vieira
Santiago Vieira
JPJonathan Peralta
Jonathan Peralta
DVDavid Viveros-Carreño
David Viveros-Carreño
JRJuliana Rodriguez
Juliana Rodriguez
JFJohn Edwin Feliciano-Alfonso
John Edwin Feliciano-Alfonso
RPRene Pareja
Rene Pareja
Objective This systematic review and meta-analysis aimed to assess the rate of sentinel lymph node (SLN) metastases in patients with a pre-operative diagnosis of atypical hyperplasia/endometrial intra-epithelial neoplasia and endometrial cancer in hysterectomy specimens. Methods A systematic literature review was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist and the protocol was registered in PROSPERO (CRD42023416769). MEDLINE, Embase, Cochrane Central Register of Controlled Trials, and Scopus databases were searched from inception until April 2023. The inclusion criteria were patients with a pre-operative diagnosis of atypical hyperplasia/endometrial intra-epithelial neoplasia undergoing hysterectomy who did or did not undergo SLN assessment. Results Four studies met the inclusion criteria. All studies were non-randomized studies with a total of 10 217 patients, 1044 in the SLN group and 9173 in the non-nodal assessment group. The unilateral and bilateral detection rate was 89% (I2=27.6%, 2 studies, 342 participants, 304 events) and 79% (I2=89.2%, 2 studies, 342 participants, 271 events), respectively. The rate of involved SLNs was 1.6% (I2=0%, 3 studies, 424 participants, 7 involved SLN) and 3.5% (I2=0%, 3 studies, 197 participants, 7 involved SLN) in patients with a pre-operative diagnosis of atypical hyperplasia/endometrial intra-epithelial neoplasia as the denominator and in those with endometrial cancer in the hysterectomy specimen, respectively. The cancer rate in the hysterectomy specimen was 45% (I2=72.8%, 3 studies, 503 participants, 224 events) and the most frequent endometrial cancer International Federation of Gynecology and Obstetrics 2009 stage was IA in 199 (89.2%) patients. The complication rate was similar between the groups. Conclusion The rate of SLN metastases in patients with pre-operative atypical hyperplasia/endometrial intra-epithelial neoplasia is less than 2%, suggesting that routine SLN evaluation may not be necessary in this population.

29 November 2022 in Gynecologic Oncology
Verified
Journal Article
Closed access
SVSantiago Vieira
Santiago Vieira
DVDavid Viveros-Carreño
David Viveros-Carreño
JRJuliana Rodríguez
Juliana Rodríguez
CGCarlos F. Grillo-Ardila
Carlos F. Grillo-Ardila
MAMartina Aida Angeles
Martina Aida Angeles
RPRene Pareja
Rene Pareja

30 July 2025 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
NMNathalia Mora‐Soto
Nathalia Mora‐Soto
CMCarolina Morante‐Caicedo
Carolina Morante‐Caicedo
MCMaria Caicedo‐Martínez
Maria Caicedo‐Martínez
DVDavid Viveros‐Carreño
David Viveros‐Carreño
EDEmmanuel Sánchez Díaz
Emmanuel Sánchez Díaz
RPRene Pareja
Rene Pareja
Cervical cancer is among the most common cancers affecting women worldwide. The standard treatment for early‐stage cervical cancer (International Federation of Gynecology and Obstetrics [FIGO] 2018 stages IA1–IB2, IIA1) typically involves a radical or simple hysterectomy with lymph node assessment. Postoperative management may include observation or tailored adjuvant therapy, such as radiotherapy or chemoradiotherapy, depending on individual pathological risk factors. However, these interventions are associated with significant complications: surgical management can lead to urinary and sexual dysfunction, lymphocysts, and lower limb lymphedema, while radiotherapy may cause genitourinary, gastrointestinal, and sexual toxicities. Less‐radical surgery for selected cases could reduce surgical morbidity and advances in radiotherapy techniques, such as intensity‐modulated radiotherapy, volumetric modulated arc therapy, and other three‐dimensional conformal radiation therapies, have the potential to enhance precision and reduce toxicity. Nonetheless, the morbidity associated with combining radical surgery and adjuvant (chemo)radiotherapy remains an area of uncertainty, particularly in light of these emerging technologies. Most current data on this topic derive from retrospective studies involving heterogeneous populations and inconsistent quality‐of‐life assessment methods. Prospective studies employing standardized morbidity assessment tools are essential to determine the true impact of combined treatments compared to single‐modality approaches. Future research should prioritize understanding the long‐term effects of these treatment strategies, aiming to minimize adverse outcomes while maintaining optimal oncological control.

20 May 2020 in Revista Colombiana de Obstetricia Y Ginecologia
Verified
Journal Article
Open access
PDF file
RARafael Leonardo Aragón-Mendoza
Rafael Leonardo Aragón-Mendoza
JAJaime Arenas-Gamboa
Jaime Arenas-Gamboa
SVSantiago Vieira
Santiago Vieira
ISIsaac Alfonso Juan Sierra
Isaac Alfonso Juan Sierra
Objetivo: reportar el caso de una paciente gestante con diagnóstico de tumor retroperitoneal primario y hacer revisión de la literatura del diagnóstico, tratamiento y pronóstico materno-fetal de esta entidad durante el embarazo. Materiales y métodos: gestante de 19 años que consulta por tumor retroperitoneal identificado por ecografía, se realizó biopsia percutánea con resultado de tumor benigno; parto por cesárea con recién nacido sano. A los 4 meses se realizó resección quirúrgica, la histopatología mostró un teratoma quístico maduro. Se realizó búsqueda en las bases de datos de: Medline vía PubMed, Lilacs, SciELO y ScienceDirect, con los términos: “embarazo”, “neoplasias” y “neoplasias retroperitoneales”, incluyendo reportes y series de caso de tumores retroperitoneales en el embarazo. Se identificó el diagnóstico, tratamiento y pronóstico materno-fetal Resultados: se identificaron 1.658 títulos, de los cuales 34 reportes de casos y una serie de casos cumplieron con los criterios de inclusión. El 62,9% eran tumores benignos. El diagnóstico se hizo como hallazgo incidental en el 63% de los casos, el ultrasonido identificó la masa en el 77%, la biopsia percutánea se utilizó en el 8% de los casos incluyendo el reportado. El tratamiento quirúrgico fue utilizado en el 88% de los casos, generalmente después del parto. Hubo mortalidad materna en el 8,5% de los casos. El pronóstico fetal fue bueno en el 65% de las gestaciones. Conclusión: los tumores retroperitoneales en la gestación, a pesar de ser principalmente benignos, tienen un pronóstico materno y fetal reservado en un importante número de casos. Se requiere evaluar los beneficios y riesgo de la biopsia percutánea.

19 March 2026 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
RPRene Pareja
Rene Pareja
NANúria Agustí
Núria Agustí
SVSantiago Vieira
Santiago Vieira
NMNathalia Mora-Soto
Nathalia Mora-Soto
ESEmmanuel Sanchez
Emmanuel Sanchez
DVDavid Viveros-Carreño
David Viveros-Carreño

8 November 2025 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
JPJonathan Peralta
Jonathan Peralta
LCLina Caicedo
Lina Caicedo
JRJuliana Rodríguez
Juliana Rodríguez
DVDavid Viveros-Carreño
David Viveros-Carreño
SVSantiago Vieira
Santiago Vieira
RPRené Pareja
René Pareja